Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Oncoclínicas do Brasil Serviços Médicos S.A. provides medical services focused on clinical oncology and radiotherapy in Latin America. It offers services in the areas of chemotherapy, radiotherapy, hormone therapy, molecular target drugs, immunotherapy, bone marrow transplant, catheter heparinization, non-oncological infusions, laser therapy, myelogram - bone marrow biopsy, continuous care, and precision medicine. The company was founded in 2010 and is based in São Paulo, Brazil.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of fair value o
Target Price
The average target price of ONCO3.SA is 3.8 and suggests 148% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell